- Home
- SFNC vs NVCR Comparison
SFNC vs NVCR Comparison
Compare SFNC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFNC
- NVCR
- Stock Information
- Founded
- SFNC 1903
- NVCR 2000
- Country
- SFNC United States
- NVCR Switzerland
- Employees
- SFNC N/A
- NVCR N/A
- Industry
- SFNC Major Banks
- NVCR Medical/Dental Instruments
- Sector
- SFNC Finance
- NVCR Health Care
- Exchange
- SFNC Nasdaq
- NVCR Nasdaq
- Market Cap
- SFNC 2.7B
- NVCR 2.3B
- IPO Year
- SFNC N/A
- NVCR 2015
- Fundamental
- Price
- SFNC $20.20
- NVCR $20.06
- Analyst Decision
- SFNC Hold
- NVCR Buy
- Analyst Count
- SFNC 3
- NVCR 5
- Target Price
- SFNC $23.33
- NVCR $33.40
- AVG Volume (30 Days)
- SFNC 662.0K
- NVCR 1.1M
- Earning Date
- SFNC 04-23-2025
- NVCR 05-01-2025
- Dividend Yield
- SFNC 4.24%
- NVCR N/A
- EPS Growth
- SFNC N/A
- NVCR N/A
- EPS
- SFNC 1.21
- NVCR N/A
- Revenue
- SFNC $728,851,000.00
- NVCR $605,220,000.00
- Revenue This Year
- SFNC $21.29
- NVCR $3.41
- Revenue Next Year
- SFNC $6.89
- NVCR $9.24
- P/E Ratio
- SFNC $16.55
- NVCR N/A
- Revenue Growth
- SFNC N/A
- NVCR 18.82
- 52 Week Low
- SFNC $16.03
- NVCR $11.70
- 52 Week High
- SFNC $25.95
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- SFNC 33.43
- NVCR 42.06
- Support Level
- SFNC $19.66
- NVCR $17.10
- Resistance Level
- SFNC $20.96
- NVCR $21.55
- Average True Range (ATR)
- SFNC 0.54
- NVCR 1.27
- MACD
- SFNC -0.14
- NVCR 0.28
- Stochastic Oscillator
- SFNC 20.15
- NVCR 56.96
About SFNC Simmons First National Corporation
Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers a range of products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. All the business activity of the firm is functioned through the region of the United States.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.